10.12 DRCR.net Protocol T
A total of 660 participants from 89 clinical sites in the U.S. were completed the study. Randomization was as follows: 224 participants in the aflibercept 2.0 mg arm, 218 in the bevacizumab 1.25 mg arm, and 218 in the ranibizumab 0.3 mg arm.
Quiz Module 10.12
To validate your answers and keep track of your progress please sign in or register a new account
1. The Protocol T study examined the comparative effectiveness of which of the following?
2. The study found that when visual acuity is 20/40 or better, there is little difference between the drugs, but at 20/50 or worse which one is more effective?